Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000895345-98-000306
Filing Date
1998-05-12
Accepted
1998-05-12 00:00:00
Documents
1
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 DEFA14A 962
  Complete submission text file 0000895345-98-000306.txt   2405
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7146683102
ICN PHARMACEUTICALS INC (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11397 | Film No.: 98616483
SIC: 2834 Pharmaceutical Preparations